In gliomas, 2HG, which is a competitive inhibitor of multiple α-KG-dependent dioxygenases, produced by mutant-IDH1, has been found to inhibit BCAT1 and BCAT2 [31, 44]. This evidence concerns the gene BCAT1 and central nervous system cancer.